European Society of Toxicology In Vitro > Uncategorized > ESTIV welcomes two new corporate members!
26 July 2021

ESTIV welcomes two new corporate members!

React4life is an Italian startup that developed MIVO® – Multi In Vitro Organ, a patented microphysiological system (MPS) able to reproduce portions of the human body improving the reliability of the testing outcome. It can easily accommodate and cultivate 3D human tissues, organoids or biopsies to suit every testing needs. MIVO® can be used as bioreactor, for enhancing tissues conditions and prolonging lifetime, for advanced drug testing assays on 3D tissues, for discovering new therapeutic approaches, and for basic research, without involving animal use. It is individually blistered, sterile, disposable, immediately ready-to-use.For more information visit:
www.react4life.com
Symrise is a global supplier of fragrances, flavors, food, nutrition and cosmetic ingredients. Its clients include manufacturers of perfumes, cosmetics, food and beverages, pharmaceuticals and producers of nutritional supplements and pet food. Its sales of € 3.5 billion in the 2020 fiscal year make Symrise a leading global provider. Headquartered in Holzminden, Germany, the Group is represented by more than 100 locations in Europe, Africa, the Middle East, Asia, the United States and Latin America. Symrise works with its clients to develop new ideas and market-ready concepts for products that form an integral part of everyday life. Economic success and corporate responsibility are inextricably linked as part of this process. In addition, Symrise has set up an animal testing policy in 2009 that aims to minimize such testing and Symrise is promoting alternative approaches wherever possible.


For more information visit:
www.symrise.com

Related content

Be aware of scammers…..

  • News

Please be aware, that ESTIV and many other EU-based societies are currently facing the incased activity of scams and fraudulent e-mails requesting bank transfers to various accounts. ….

Advances in genotoxicity testing: Reconstructed skin Comet and Micronucleus Assays – January 21, 2022

  • News

Advances in Genotoxicity: News and views on the Genotoxicity testing with reconstructed skin by two industrial experts. Dr. Stefan Pfuhler, Procter and Gamble and Dr. Kerstin Reisinger, Henkel AG & Co. KGaA.

Season’s greetings from ESTIV Board

  • News

We wish you the best of holidays and a prosperous year 2022! Please follow us also in 2022.

Gold Sponsor

Silver Sponsor

Corporate Members

Affiliated Societies

Memorandum of Understanding